Skip to main content

Market Overview

Benzinga's Top Pre-Market Losers


Neurocrine Biosciences (NASDAQ: NBIX) shares dropped 27.25% to $12.15 in pre-market trading after the company reported Phase IIb results Of VMAT2 Inhibitor NBI-98854 for treatment of tardive dyskinesia.

ChemoCentryx (NASDAQ: CCXI) dipped 15.25% to $7 in the pre-market session after the company announced top-line interim results for CCX140 in an ongoing Phase II trial.

HD Supply Holdings (NASDAQ: HDS) dipped 8.68% to $22.60 in the pre-market session on Q2 results.

Urban Outfitters (NASDAQ: URBN) shares fell 6.58% to $39.90 in the pre-market trading. William Blair cut its Q3 earnings view for Urban Outfitters to 45c.


Related Articles (NBIX + CCXI)

View Comments and Join the Discussion!

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at